These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2292916

  • 1. [Lovastatin: short-term treatment of hypercholesterolemia; multicenter clinical trial].
    Brusco OJ.
    Medicina (B Aires); 1990; 50(1):69-73. PubMed ID: 2292916
    [Abstract] [Full Text] [Related]

  • 2. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N, Ramires JA.
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P, Walters EJ, Cullen EI, Niecestro R, Friedhoff LT.
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Jun; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 6. Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V.
    Biesenbach G, Zazgornik J.
    Clin Nephrol; 1992 Jun; 37(6):274-9. PubMed ID: 1638777
    [Abstract] [Full Text] [Related]

  • 7. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
    Itskovitz HD, Flamenbaum W, De Gaetano C, Pritchard KA, Stemerman MB.
    Clin Ther; 1989 Jun; 11(6):862-72. PubMed ID: 2611825
    [Abstract] [Full Text] [Related]

  • 8. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
    Sánchez Domínguez J, Rodríguez Padial L, Navarro A, Barcina C, Fernández E, Rivera G, Cuesta L, Lázaro-Carrasco E.
    Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368
    [Abstract] [Full Text] [Related]

  • 9. [Lovastatin in the treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus patients].
    Zanella MT, Plavinik F, Zampieri M, Peres RB, Ribeiro AB.
    Arq Bras Cardiol; 1993 Jul; 61(1):27-31. PubMed ID: 8285861
    [Abstract] [Full Text] [Related]

  • 10. [Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study].
    Ose L.
    Tidsskr Nor Laegeforen; 1992 Nov 30; 112(29):3665-9. PubMed ID: 1471127
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp RH, Tun P, Zupkis RV, Greguski RA.
    Arch Intern Med; 1994 Jul 25; 154(14):1586-95. PubMed ID: 8031206
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Lowering of the plasma lipid concentration with lovastatin. A clinical study in patients with primary hypercholesterolemia].
    Grüneberger S, Dreyer M, Kangah R, Reinicke A, Staisch C, Steinhagen-Thiessen E, Müller P, Simon B, Dammann HG.
    Dtsch Med Wochenschr; 1989 Nov 10; 114(45):1734-9. PubMed ID: 2806106
    [Abstract] [Full Text] [Related]

  • 15. [Effects of lovastatin in primary hypercholesterolemia].
    Nakandakare ER, Garcia RC, Carré JM, Zerbinatti CV, Oliveira HC, Quintão EC.
    Arq Bras Cardiol; 1989 May 10; 52(5):291-5. PubMed ID: 2690785
    [Abstract] [Full Text] [Related]

  • 16. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W.
    Int J Clin Pharmacol Ther; 1994 Feb 10; 32(2):92-7. PubMed ID: 8004365
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 10; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 19. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR, Tandon M, Sharma PL.
    Int J Clin Pract; 2007 Nov 10; 61(11):1812-8. PubMed ID: 17935545
    [Abstract] [Full Text] [Related]

  • 20. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
    Romics L, Karádi I, Csanády M, Gógl A, Jánosi A, Ofner P, Tarján J, Varga L, Wórum F, Zeltner G.
    Orv Hetil; 1994 Oct 02; 135(40):2187-91. PubMed ID: 7970631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.